Prospective, Randomized, Controlled, Phase II Multiple Centered Clinical Trial of Nimotuzumab Combined With Radiotherapy for Senile Locally Advanced SCCHN.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Jul 2011 New trial record